Previous Close | 1.4000 |
Open | 1.4000 |
Bid | 1.3300 x N/A |
Ask | 1.3400 x N/A |
Day's Range | 1.3300 - 1.4100 |
52 Week Range | 1.0600 - 3.2300 |
Volume | |
Avg. Volume | 71,549 |
Market Cap | 139.379M |
Beta (5Y Monthly) | 2.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1990 |
Earnings Date | May 16, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.50 |
Infant Formula Infant Formula VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler, and children nutrition company, announces that it completed initial commercial production in April of its infant formula, to be used in key Clinical Studies for the U.S. market. Following the commercial production, Else will conduct clinical trials to validate product safety and benefits for regula
VANCOUVER, BC / ACCESSWIRE / May 18, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Nextech AR Solutions, Else Nutrition, Banyan Gold, Eat Well Group, and Trillion Energy on their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.
VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC (BABY) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler, and children nutrition company, today adjusted guidance for 2Q22 growth projection. 2Q22 Outlook: Else Nutrition expects revenues in the Second Quarter of 2022 to be in the range of $2M to $2.2M, representing a 25% to 38% increase over 1Q22. We are seeing robust preliminary results as a reflection of the deep crisis in the baby